// Company Overview //
| Stock Name | 瑞慈醫療服務控股有限公司 |
| Stock Code | 01526 |
| Company Full Name | 瑞慈醫療服務控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國從事經營綜合醫院、專科醫院、體檢中心及診所。 |
| Listing Date | 2016-10-06 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市靜安區江寧路212號凱迪克大廈4樓 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | No data |
| Listing Method | No data |
| Listing Board | Main Board |
| Website | http://www.rich-healthcare.com |
| Share Registrar | 香港中央證券登記有限公司 |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Prospectus Date | 2016-09-26 |
| Offer Price | HK$ 2.56 / shares |
| Total Funds Raised | HK$ 101,785,600 |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 2.44 |
| First Day Change | -7.81% |
| First Day Volume | 45462000.0 |
| First Day Turnover | 108719000.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、所得款項凈額約83.5%或660.1百萬港元將用于擴充計劃;
2、所得款項凈額約11%或87.1百萬港元將用于償還部分銀行及其他借款;
3、余款將作額外營運資金及其他一般公司用途。 |
// Underwriting Syndicate //
联席保荐人 (2)
法国巴黎证券(亚洲)有限公司
瑞士信贷(香港)有限公司
整体协调人 (4)
法国巴黎证券(亚洲)有限公司
瑞士信贷(香港)有限公司
招银国际融资有限公司
中银国际亚洲有限公司
联席账簿管理人 (4)
法国巴黎证券(亚洲)有限公司
瑞士信贷(香港)有限公司
招银国际融资有限公司
中银国际亚洲有限公司
联席牵头经办人 (5)
法国巴黎证券(亚洲)有限公司
瑞士信贷(香港)有限公司
招银国际融资有限公司
中银国际亚洲有限公司
太平基业证券有限公司
// Cornerstone Investors //
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
| 1 |
Wonderful Leader Limited |
76,800,000 HKD |
— |
1.89% |
— |
6 months |
2017-04-06 |
| 2 |
绿地金融海外投资集团有限公司 |
200,000,000 HKD |
— |
4.91% |
— |
6 months |
2017-04-06 |
// Directors & Management //
| Chairman | 方宜新 |
| Company Secretary | 李杏韶 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 方宜新(54.87%);The Baring Asia Private Equity Fund V, L.P.(16.87%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.